CellSeed Inc. (7776.T)

JPY 408.0

(-7.69%)

Annual Income Statements

(In JPY)
Breakdown 2023 2022 2021 2020 2019
Revenue 190.13 Million 126.42 Million 161.67 Million 199.46 Million 275.82 Million
Cost of Revenue 82.97 Million 65.4 Million 77.63 Million 61.27 Million 59.19 Million
Gross Profit 107.15 Million 61.01 Million 84.03 Million 138.18 Million 216.62 Million
Operating Expenses 804.93 Million 804.23 Million 948.14 Million 857.7 Million 1.04 Billion
Selling, General and Administrative Expenses 348.51 Million 359.47 Million 387 Million 402 Million 451.24 Million
Research and Development Expenses 456.41 Million 444.75 Million 541.24 Million 438.83 Million 591.35 Million
Other Expenses - 256 Thousand 193 Thousand 212 Thousand -
Cost and Expenses 887.91 Million 869.64 Million 1.02 Billion 918.98 Million 1.1 Billion
Operating Income -697.77 Million -743.21 Million -864.1 Million -719.52 Million -825.97 Million
Interest Expense 1.12 Million 835 Thousand 911 Thousand 152 Thousand -
Income Tax Expense 950 Thousand 950 Thousand 3.8 Million 3.8 Million -172 Thousand
Earnings before Tax -845.58 Million -758.73 Million -909.07 Million -780.06 Million -782.57 Million
Net Income -846.53 Million -759.68 Million -912.87 Million -783.86 Million -782.39 Million
Earnings Per Share Basic -29.43 -36.31 -53.08 -55.31 -66.60
Earnings Per Share Diluted -29.43 -36.31 -53.08 -55.31 -66.60
Weighted Average Shares Outstanding 28.76 Million 20.92 Million 17.19 Million 14.17 Million 11.74 Million
Weighted Average Shares Outstanding (Diluted) 28.76 Million 20.92 Million 17.19 Million 14.17 Million 11.74 Million
Gross Margin 0.56 0.48 0.52 0.69 0.79
EBIT Margin -4.40 -5.90 -5.33 -3.68 -2.97
Profit Margin -4.45 -6.01 -5.65 -3.93 -2.84
EBITDA -836.51 Million -750 Million -905.67 Million -770.13 Million -776.89 Million
Earnings Before Tax Margin -3.67 -5.88 -5.34 -3.61 -2.99

Income Statement Charts